Skip to content

EU survey finds widespread ignorance of HIV transmission risks

Atazanavir/efavirenz NRTI-sparing regimen effective, but raises lipid levels

Nevirapine hepatotoxicity after treatment switch no more likely at higher CD4 counts

HIV prevalence among young women in Botswana falls to lowest level since early 1990s, but still high

No fat loss with tenofovir after five years

International drug purchase fund kicks off with support for paediatric & second-line HIV treatment

HIV-positive patients have increased risk of side-effects to key drugs used to treat opportunistic infections

Systematic review suggests smoking increases HIV infection risk

Recombinant human growth hormone reduces visceral fat in two randomised studies